Woo, Hawon, et al. “Pharmacological Targeting of the NLRP3 TrLRR Domain With Isothiazolinones Overcomes CRID3-Resistant Inflammation”. LangTaoSha Preprint Server, 30 Jan. 2026, https://doi.org/10.65215/LTSpreprints.2026.01.30.000113.